Abbott Laboratories (ABT): Mairs & Power Inc reduced its stake -115K shares
Mairs & Power Inc reduced its stake in Abbott Laboratories, per its Q2 2025 13F.
- 902K
- Shares reported · -115K vs prior quarter
- 1.2%
- Disclosed portfolio weight
- $123M
- Reported value
- Holdings as of
- Jun 30, 2025
- Filed
- Aug 14, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 15, 2023CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
- May 12, 2025CongressDisclosed sale of ABT — reported range $50,001 - $100,000
- Jun 24, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
- Jul 10, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
- Jul 18, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
- Jul 21, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
- Aug 8, 2025InsiderCFO sold ~$747K of ABT shares in the open market
- Aug 14, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
What came next
- Sep 10, 2025FDARecall: TactiFlex Sensor Enabled Ablation Catheter, 8F, 115 cm, FJ, (BiD Curve F-J), REF A-TFSE-FJ; cardiac catheter
- Sep 10, 2025FDARecall: TactiFlex Sensor Enabled Ablation Catheter, 8F, 115 cm, DD, (BiD Curve D-D), REF A-TFSE-DD; cardiac catheter
- Sep 17, 2025FDAFDA device clearance: Assert-IQ (DM5000); Assert-IQ (DM5300); Assert-IQ (DM5500); Merlin.net (MN7000)
- Sep 18, 2025FDARecall: Brand Name: Alinity hq Analyzer Product Name: Alinity hq Analyzer Model/Catalog Number: 09P68-01 Software Version: 5.0 to 5.10.1 for OUS, 5.7 and 5.10.1 in the…
- Sep 25, 2025FDAFDA device clearance: Alinity m HCV
- Sep 25, 2025FDAFDA device clearance: EnSite X EP System
- Oct 3, 2025FDAFDA device clearance: Amplatzer Guidewire
- Oct 6, 2025FDARecall: Eterna SCS IPG (Implantable Pulse Generator), Model Number 32400
- Oct 6, 2025FDARecall: Liberta RC DBS IPG (Implantable Pulse Generator), Model Number 62400
- Oct 6, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
- Oct 15, 2025Company filing · Form 8-K · ResultsReported its results
- Oct 29, 2025FDAFDA device clearance: Seguin Annuloplasty Ring
- Nov 5, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
- Nov 13, 2025FDARecall: Alinity ci-series System Control Module (SCM), REF: 03R70-01, 03R70-20
- Nov 13, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
- Nov 18, 2025Company filing · Form 8-K · Temporary Suspension of Trading Under Registrant's Employee Benefit PlansSuspended trading under its employee plans
- Nov 19, 2025Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
- Nov 24, 2025FDARecall: FreeStyle Libre 3 Sensor REF 72081-01 UDI-DI code: 00357599818005 The FreeStyle Libre 3 sensor is a component of the FreeStyle Libre 3 Continuous Glucose Monit…
- Nov 24, 2025FDARecall: FreeStyle Libre 3 Plus Sensor REF 78768-01 UDI-DI code: 00357599844011 The FreeStyle Libre 3 Plus sensor is a component of the FreeStyle Libre 3 Continuous Glu…
- Nov 24, 2025FDARecall: FreeStyle Libre 3 Plus Sensor REF 78769-01 UDI-DI code: 00357599843014 The FreeStyle Libre 3 Plus sensor is a component of the FreeStyle Libre 3 Continuous Glu…
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Abbott Laboratories
For Abbott Laboratories, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 3 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.
How this filing works
Explore the data
Common questions
What does this filing report about Abbott Laboratories (ABT) stock?
Mairs & Power Inc reduced its stake in Abbott Laboratories, per its Q2 2025 13F. Now 902K shares, $123M reported value, 1.2% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Jun 30, 2025. Filed: Aug 14, 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Abbott Laboratories recently?
For Abbott Laboratories, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 3 fund holdings reports (13F) dated in the last 90 days. They are listed on the ABT page.
Does this mean ABT stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Abbott Laboratories
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 6, 2026
- SEC Form 144Nov 5, 2026
- House Clerk periodic transaction reportOct 30, 2026
- House Clerk periodic transaction reportOct 27, 2026
- House Clerk periodic transaction reportOct 12, 2026
Everything OQRO holds on this company is on its ABT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
